Is BriaCell Therapeutics Corp. (BCTX) Halal?
Shariah Screening — 5 Standards
Based on financial data from July 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 3.1% / 30% | 4.9% / 30% | N/A | ✓ HALAL |
| DJIM | 0.0% / 33% | 3.1% / 33% | 4.9% / 33% | N/A | ✓ HALAL |
| MSCI | 0.0% / 33% | 14.7% / 33% | 23.3% / 33% | N/A | ✓ HALAL |
| S&P | 0.0% / 33% | 3.1% / 33% | 4.9% / 33% | N/A | ✓ HALAL |
| FTSE | 0.0% / 33% | 14.7% / 33% | 23.3% / 50% | N/A | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -179.2% | |
| Return on Assets (ROA) | -89.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$24M |
| Free Cash Flow | -$25M |
| Current Ratio | 10.1 |
| Total Assets | $6M |
Price & Trading
| Last Close | $3.89 |
| 50-Day MA | $4.17 |
| 200-Day MA | $10.14 |
| Avg Volume | 501K |
| Beta | 1.8 |
|
52-Week Range
$3.60
| |
About BriaCell Therapeutics Corp. (BCTX)
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BriaCell Therapeutics Corp. (BCTX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BriaCell Therapeutics Corp. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BriaCell Therapeutics Corp.'s debt ratio?
BriaCell Therapeutics Corp.'s debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.0%.
What are BriaCell Therapeutics Corp.'s key financial metrics?
BriaCell Therapeutics Corp. has a market capitalization of $27M. Return on equity stands at -179.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.